Biogen Invest Advisor

Biogen (BIIB) Loses -6.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Nov 5, 2024

Faruqi & Faruqi Advocates for Biogen Investor Rights Jul 19, 2024

European Commission Withdraws Approval for Generic TECFIDERA® - Impact on Biogen BIIB Dec 20, 2023